asiagame官方网站

  • 6332a21930609
    Cancel
    Date：2022-09
    /index.php?a=shows&catid=34&id=725

    Worg Pharmaceuticals, a biopharmaceutical company dedicated to providing breakthrough immune therapy solutions, announced the successful closing of nearly RMB 400 million in its Series B financing. Investors in this round of funding included Junson Capita

  • 636c5c4743cc6
    Cancel
    Date：2022-09
    /index.php?a=shows&catid=34&id=727

    BoomRay Pharmaceuticals is at the forefront of creating next-generation targeted radionuclide-conjugated drugs. HongShan led this round, with participation from Riverhead Capital, Tririver Capital, Puhua Capital, Tsing Song Capital, Life Sciences Investme

  • 630887a317279
    Cancel
    Date：2022-08
    /index.php?a=shows&catid=34&id=728

    Raintech, a leading smart IoT production management platform for greenhouses, announced the successful closing of its Series A financing, with Shunwei Capital investing millions of RMB. The funds will be primarily used for product research and development

  • 62b13ac2673b4
    Cancel
    Date：2022-06
    /index.php?a=shows&catid=34&id=729

    Therorna Inc. is dedicated to the development of novel vaccines and therapies in multiple cutting-edge treatment areas, focusing on international frontier circular RNA (circRNA) technology. This funding round was led by MSA Capital and a renowned industri

  • 63b3df9c39069
    Cancel
    Date：2022-06

    Exclusive Financial Advisor to the founders of Taikang Bybo Dental

  • 629daceb68b64
    Cancel
    Date：2022-06
    /index.php?a=shows&catid=34&id=730

    Sihuan Pharm announced that its non-wholly-owned subsidiary, Huisheng Pharm, has completed a RMB 500 million Series A financing. This round was invested by China Life Chengda (Shanghai) Health Industry Equity Investment Centre (L.P.), GF Investment, GF In

  • 6285b936a0cd9
    Cancel
    Date：2022-05
    /index.php?a=shows&catid=34&id=731

    Senlang Biotechnology announced the successful closing of RMB 200 million from Qianhai Ark Asset Management. CEC Capital Group acted as the exclusive financial advisor for Senlang Biotechnology in this transaction.

  • 665d354e7583d
    Cancel
    Date：2022-05

    Exclusive Financial Advisor to DOBOSO

  • 6278d77980e65
    Cancel
    Date：2022-04
    /index.php?a=shows&catid=34&id=732

    Fosun Pharmaceutical recently announced that its subsidiary, YanengBIO, along with its existing shareholders, has entered into a relevant agreement with Yaneng Bioscience under CBridge Capital. Upon completion of the transaction, YanengBIO will transition


【网站地图】